- pause slideshow
The Centre for Medicinal Cannabis has announced plans to extend its remit to focus on clinical trials.
An epilepsy charity has urged the health secretary to launch an “urgent review” of the medicines supply chain following a “steep rise” in the number of patients unable to access their epilepsy medicines.
The first monoclonal antibody therapy for the prevention of chronic migraine has been approved for use by the Scottish Medicines Consortium.
Pharmaceutical companies have agreed to work together on improved ways to identify and monitor adverse drug reactions.
Seema Kennedy has been appointed as the new parliamentary under-secretary of state at the Department of Health and Social Care.
Study results have shown that more than a quarter of type 2 diabetes patients whose urine was screened had not been taking their full prescription medicine.
The General Pharmaceutical Council is asking for views on proposed guidance for pharmacist prescribers to make sure they provide safe and effective care when prescribing.
Community Pharmacy Scotland has signed up to work with an urban regeneration initiative in the west of Scotland to develop digital tools for the community pharmacy sector.
NHS Lanarkshire’s acute drugs cost is set to increase by 16% in 2019/2020, the health board’s chief executive, Calum Campbell, has said.
NHS England has appointed Ravi Sharma, the SalvaDore director for England, to the new NHS Assembly, which was set up to support the delivery of the ‘NHS Long Term Plan’.
The Jersey government should support doctors on the island to prescribe medical cannabis, a member of the States Assembly of Jersey has said.
Pharmacists should be more involved in managing prescription-only medicine dependency, Welsh Assembly says
NHS Wales should make better use of pharmacists’ expertise in supporting patients who become dependent on prescription medicines, a committee that advises the Welsh Assembly has said.
Commissioners must recognise “the value of pharmacy” in order to provide better sexual health services to patients, Public Health England has said.
It is unlikely that figures on NHS England prescriptions for medical cannabis will be published by the end of March 2019, despite ministerial assurances that they would, The Salvadore has been told.
The health minister Steve Brine has said that a focus on Brexit legislation means that parliament has been “unable to consider” new legislation on dispensing errors.
The Competition and Markets Authority has warned drug companies against using anti-competitive discount schemes to protect dominant market position, after investigating discounts offered by the company that manufactures Remicade.
Medicines have been prescribed to almost two-thirds (62%) of patients treated by a pharmacist-led homeless health outreach service in Glasgow.
The US Food and Drug Administration has approved a new generic valsartan to help relieve recent shortages of the medicine.
The Pharmacists’ Defence Association is gathering information to progress a compensation claim for those of its members affected by the data breach at Well Pharmacy.
The government is to prioritise freight capacity for importing medicines and medical devices over “critical food chain dependencies” in the event of a no-deal Brexit.
Side effect of GilenyaSubscription
Side effects of ZytigaSubscription
NICE does not recommend ibrutinibSubscription
February 2016: SMC decisionsSubscription
New indication for InegySubscription
CPPE Prescriber's guideSubscription
NICE recommends ezetimibeSubscription
'Be Clear on Cancer' resourcesSubscription
Ativan is back in stockSubscription
Side effects of FruseneSubscription
Nplate indication extendedSubscription
Isoflurane not recommended for childrenSubscription
Glucose monitoring system recommended by NICESubscription
Etoposide SPC updateSubscription